Will India remain a generics destination or move beyond...
Time and again Indian pharma has proved its prowess in the field of generics. But standing at an inflection, it’s time now that it take its flight towards the research space and unleashes its true potential in the coming years...
The Indian pharmaceutical industry is today at an inflection point. While the industry has gained global recognition for its high-quality affordable generic products, it is now poised to gain its foothold in the area of New Drug Discovery Research.
Time and again we have proved our prowess in the field of science & technology and I strongly feel the day is not far when India will come out with its first New Chemical Entity (NCE).
I certainly feel that leading Indian pharma companies like Ranbaxy will achieve significant success in drug discovery research and have the potential to roll out multiple molecules in the global pharmaceutical market in the coming decade. Why I say that with optimism is because of the following reasons. India is a power house of scientific talent, strong chemistry skills and cutting edge research and innovation capabilities and we are way ahead on the knowledge platform over the developed nations. Our country offers significant cost advantage in innovation and manufacturing, maintaining high levels of productivity. In fact these inherent strengths are attracting and compelling big pharma players to collaborate with leading Indian companies to churn out new drug molecules.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
Time and again Indian pharma has proved its prowess in the field of generics. But standing at an inflection, it’s time now that it take its flight towards the research space and unleashes its true potential in the coming years...
The Indian pharmaceutical industry is today at an inflection point. While the industry has gained global recognition for its high-quality affordable generic products, it is now poised to gain its foothold in the area of New Drug Discovery Research.
Time and again we have proved our prowess in the field of science & technology and I strongly feel the day is not far when India will come out with its first New Chemical Entity (NCE).
I certainly feel that leading Indian pharma companies like Ranbaxy will achieve significant success in drug discovery research and have the potential to roll out multiple molecules in the global pharmaceutical market in the coming decade. Why I say that with optimism is because of the following reasons. India is a power house of scientific talent, strong chemistry skills and cutting edge research and innovation capabilities and we are way ahead on the knowledge platform over the developed nations. Our country offers significant cost advantage in innovation and manufacturing, maintaining high levels of productivity. In fact these inherent strengths are attracting and compelling big pharma players to collaborate with leading Indian companies to churn out new drug molecules.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
Read these article :-
ZEE BUSINESS BEST B SCHOOL SURVEY
B-schooled in India, Placed Abroad (Print Version)
IIPM in Financial times (Print Version)
IIPM makes business education truly global (Print Version)
The Indian Institute of Planning and Management (IIPM)
IIPM Campus
4 comments:
Time and again Indian pharma has proved its prowess in the field of generics, great article bro
nice article dude
The Indian pharmaceutical industry is today at an inflection point
iipm rockz
Post a Comment